Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. However, when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.Cash flow can come from bond interest, interest from other types of investments, and, of course, dividends. A dividend is the distribution of a company's earnings paid out to shareholders; it's often viewed by its dividend yield, a metric that me ...

Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. However, when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.Cash flow can come from bond interest, interest from other types of investments, and, of course, dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by its dividend yiel ...

As a financial analyst here on Seeking Alpha, I enjoy analyzing different stocks on the daily. I'm someone who's always in the stock market looking for a potential deal. But recently, I've been thinking about the idea ofFormerly known as "The Dividend Collectuh." Top 1% of financial experts on TipRanks. Contributing analyst to the iREIT+Hoya Capital investment group. Dividend Collection Agency is not a registered investment professional nor financial advisor and these articles should not be taken as financi ...

The Straits Times Index (SGX: ^STI) recently breached new highs, past the 5,000 level, before reversing down.With the index near fresh highs, investors are confronted with the old, so familiar feeling of the fear of missing out (FOMO); is it too late to buy stocks now?History shows that when indexes make new highs, further gains usually follow suit. However, fresh highs also mean elevated valuations; your individual stock selection now matters more than ever.  In this article, we take a look at three compan ...

Company Overview - Johnson & Johnson (J&J) is a leading company in the multitrillion-dollar global healthcare industry, with total healthcare spending in the U.S. surpassing $5.3 trillion in 2024 and growing at mid- to high single-digit rates [3] - The company develops and sells a wide range of pharmaceutical drugs and medical devices, with over 75% of its sales coming from products that hold top-two market share positions in their respective applications [4] Financial Strength - J&J has a strong financial position, allowing it to invest in new product development, acquire emerging competitors, and consistently raise its dividend [5] - The stock currently yields 2.1%, with management having raised the dividend for 63 consecutive years, making it a reliable income source for investors [6] - J&J is one of only two companies with the highest available credit rating (AAA), ensuring access to debt when needed [6] Market Position and Growth Potential - With a market capitalization approaching $590 billion, J&J is one of the world's largest companies, indicating stability rather than rapid wealth generation [7] - Management believes that the business could accelerate to double-digit growth by the end of this decade, suggesting potential upside for investors [7]

Core Viewpoint - Merck (NYSE: MRK) presents a compelling investment opportunity due to its attractive dividend yield and strong business fundamentals, despite the focus on GLP-1 weight-loss therapies in the pharmaceutical sector [1]. Dividend Attractiveness - Merck's current dividend yield is 2.8%, significantly higher than the S&P 500's yield of 1.1% and the average pharmaceutical stock yield of 1.7%, making it over 60% higher than the average drug stock [2]. - The company has a history of steadily increasing its dividend over the past 35 years, enhancing its appeal to dividend investors [3]. - Although there have been periods of steady dividends, this reflects management's commitment to supporting dividends during challenging times, recognizing their importance to investors [4]. Future Dividend Growth - Over the past decade, Merck's dividend has nearly doubled, with a current payout ratio of 45%, indicating potential for future dividend growth and compounding through reinvestment [5]. - The company is well-positioned to continue supporting its dividend while investing in new innovations [6]. Business Strengths - Merck has strong positions in cardiometabolic disease, cancer, and infection care, with ongoing developments to extend patent protections for its oncology drug Keytruda beyond the 2028 U.S. patent expiration [6]. - The company is working on a pill version of Keytruda, which could further extend patent protections into the 2030s [6]. Investment Opportunity - While not as high-profile as competitors like Eli Lilly, Merck offers a steady investment opportunity for those looking to build wealth through dividends [7]. - The company is recognized as a well-run drugmaker that rewards dividend investors for their loyalty [7].

Core Viewpoint - Vistra Corp (NYSE:VST) is a significant entity in the utilities sector, maintaining an "Overweight" rating from Morgan Stanley despite a price target adjustment from $227 to $215, indicating confidence in its stock potential [1][5] Dividend Analysis - Vistra offers an annual dividend of $0.91 per share, resulting in a dividend yield of 0.5%, which is lower than CMS Energy's $2.28 per share and 3.0% yield [2] - The company allocates 32.9% of its earnings to dividends, reflecting a conservative approach compared to CMS Energy's 64.6% [2] - Vistra has increased its dividend for six consecutive years, surpassing CMS Energy's three-year streak, indicating a strong commitment to returning value to shareholders [3][5] Stock Performance - Currently, VST is priced at $172.15, with a slight decrease of 0.20% from the previous day, and has experienced a trading range of $169.86 to $173.50 today [4] - Over the past year, VST has seen a high of $219.82 and a low of $90.51, indicating significant volatility [4] - The company's market capitalization is approximately $58.3 billion, with a trading volume of 1,075,727 shares today [4]

Key Takeaways Dividend ETFs are quietly beating the S&P 500 in 2026, amid geopolitical tensions and tech-sector weakness.While Japan-focused DFJ surges on election optimism, SCHD, HDV and EYLD offer quality dividend exposure.Wall Street has delivered a moderate performance so far this year. SPDR S&P 500 ETF Trust (SPY) has gained about 0.2% so far this year, SPDR Dow Jones Industrial Average ETF Trust (DIA) has added about 2.2%, the Nasdaq-100 ETF Invesco QQQ Trust, Series 1 (QQQ) has lost about 1.6% and iS ...

Core Viewpoint - Recent volatility in gold prices highlights that even traditionally safe assets are subject to market fluctuations, prompting investors to consider a "prosperity portfolio" of dividend-paying stocks as an alternative [1] Group 1: Prosperity Portfolio Definition - A prosperity portfolio focuses on long-term compounding of a resilient income stream rather than speculation [3] - Companies included should have strong cash flow, a proven dividend payment history, and competitive advantages [3] - Investors should assess free cash flow consistency to ensure dividends are funded by operational cash rather than debt [4] Group 2: Company Analysis for Prosperity Portfolio Singapore Exchange Ltd (SGX: S68) - SGX is a blue-chip stock with a reliable dividend history, offering a 2.1% dividend yield and a payout ratio of 68% [6] - The company has increased free cash flow from S$502 million in FY2021 to S$774 million in FY2025, with a slight decrease in the first half of FY2026 [7] - SGX's high return on equity of 33.9% and low gearing ratio of 0.3 suggest dividend safety even in adverse economic conditions [8] Singapore Technologies Engineering Ltd (SGX: S63) - ST Engineering has a current dividend yield of 2.3% with potential for growth due to rising demand in its sectors [9] - The company has maintained or increased dividends from 2017 to 2024, with a special dividend of S$0.05 per share expected in 2025 [11] - Despite a weak balance sheet with S$5.5 billion in debt, ST Engineering has generated positive free cash flow consistently, reaching S$1.2 billion in 2024 [13] Sembcorp Industries Ltd (SGX: U96) - Sembcorp offers the highest dividend yield at 4.1%, with dividends increasing from S$0.04 in 2020 to S$0.23 in 2024 [14] - The company recently acquired Alinta Energy, which is expected to enhance earnings despite taking on S$6.1 billion in debt [16] - Sembcorp has generated an average annual free cash flow of S$1.5 billion from 2020 to 2024, with a 42% YoY increase in free cash flow to S$1.3 billion in the first half of 2025 [17] Group 3: Portfolio Construction Guidelines - Diversification across sectors is crucial to avoid concentration risk, with selections spanning finance, defense, and energy [18] - While higher dividend yields are attractive, caution is advised as they may indicate unsustainable dividends [18] - Reinvesting dividends is recommended to compound returns over time, contributing to long-term financial independence [19]

Group 1 - DHT Holdings (DHT) has seen a 36% increase year-to-date, trading at $16.64 as of February 18, 2026, and distributes 100% of net income as quarterly dividends [1] - DHT reported Q4 2025 revenue of $144.16 million, exceeding estimates by 24%, with VLCC spot rates averaging $69,500 per day, a significant rise from $38,200 per day in Q4 2024 [1] - The company has secured a one-year charter for DHT Opal at $90,000 per day starting February 2026, which will contribute to its dividend payouts [1] Group 2 - DHT's Q4 2025 net income was $66 million, leading to a dividend of $0.41 per share, marking the 64th consecutive quarterly dividend [1] - For Q1 2026, DHT has locked in 76% of spot days at $78,900 per day, while four newbuildings are expected to deliver in the first half of 2026 [1] - Analysts have a consensus rating of "Strong Buy" for DHT, with a price target of $16.33, and the stock has a forward P/E of 9 and a yield of 10.1% [1] Group 3 - The sustainability of DHT's dividend payouts is contingent on day rates remaining above the breakeven level of $18,300 for Q1 2026 [1] - DHT's dividend history shows volatility, with payouts of $1.15 in 2023, $1.00 in 2024, and $0.74 in 2025, although the recent $0.41 payout is the highest on record [1] - Operating cash flow decreased to $276 million in 2025 from $298 million in 2024, with capital expenditures of $309 million resulting in negative free cash flow [1]